XML 60 R45.htm IDEA: XBRL DOCUMENT v3.19.1
Other Income and Expense
12 Months Ended
Dec. 31, 2018
Disclosure of other operating income (expense) [Abstract]  
Other Income and Expense
40.

Other Income and Expense

 

(1)

Other income for the years ended December 31, 2016, 2017 and 2018 are as follows:

 

            2016      2017      2018  
            In millions of won  

Reversal of other provisions

            22,034        35,265        12,700  

Reversal of other allowance for doubtful accounts

        5,489        2,166        143  

Gains on government grants

        111        430        482  

Gains on assets contributed

        12,254        4,218        17,336  

Gains on liabilities exempted

        1,959        3,166        10,303  

Compensation and reparations revenue

        114,530        89,196        89,901  

Revenue from research contracts

        13,143        12,580        6,818  

Income related to transfer of assets from customers

        427,297        478,973        594,548  

Rental income

        211,580        192,136        186,631  

Others

        31,787        50,988        51,032  
     

 

 

    

 

 

    

 

 

 
            840,184        869,118        969,894  
     

 

 

    

 

 

    

 

 

 

 

(2)

Details of others of other income for the years ended December 31, 2016, 2017 and 2018 are as follows:

 

            2016      2017      2018  
            In millions of won  

Refund of claim for rectification

            8,722        9,655        8,933  

Adjustment of research project

        4,148        3,884        2,267  

Maintenance expenses on lease building

        354        135        176  

Training expenses

        4,478        3,045        3,220  

Deposit redemption

        991        34        7  

Reversal of expenses on litigation

        893        360        753  

Revenue on royalty fee

        2,486        2,888        6,909  

Reimbursement of insurance fee

        —          1,498        7,145  

Gains on guarantee contracts

        2,796        456        39  

Others

        6,919        29,033        21,583  
     

 

 

    

 

 

    

 

 

 
            31,787        50,988        51,032  
     

 

 

    

 

 

    

 

 

 

 

(3)

Other expense for the years ended December 31, 2016, 2017 and 2018 are as follows:

 

          2016      2017      2018  
          In millions of won  

Compensation and indemnification expense

          —          37        23,437  

Accretion expenses of other provisions

      4,556        7,535        41,924  

Depreciation expenses on investment properties

      678        1,176        923  

Depreciation expenses on idle assets

      6,639        6,644        6,547  

Other bad debt expense

      4,585        1,778        17,827  

Donations

      114,094        119,421        63,743  

Others

      58,072        43,464        76,929  
   

 

 

    

 

 

    

 

 

 
          188,624        180,055        231,330  
   

 

 

    

 

 

    

 

 

 

 

(4)

Details of others of other expense for the years ended December 31, 2016, 2017 and 2018 are as follows:

 

           2016      2017      2018  
           In millions of won  

Operating expenses related to the idle assets

           459        136        47  

Research grants

       1,461        1,180        461  

Supporting expenses on farming and fishing village

       15,201        11,956        13,537  

Operating expenses on fitness center

       2,706        3,498        4,788  

Expenses on adjustment of research and development grants

       —          806        404  

Taxes and dues

       4,582        2,270        199  

Expenses on R&D supporting

       690        5,459        53  

Others(*)

       32,973        18,159        57,440  
    

 

 

    

 

 

    

 

 

 
           58,072        43,464        76,929  
    

 

 

    

 

 

    

 

 

 

 

(*)

Others include ₩38,886 million of impairment loss on construction-in-progress of Cheonji unit 1 and 2 and Daejin unit 1 and 2 as described in note 2.